Last reviewed · How we verify

NCT05285852

Effects Of Dry Needling On Sternocleidomastoid Muscle For Pain And Disability In Migraine

Completed NA Last updated 19 May 2022
What this trial tests

NA trial testing Dry Needling in Migraine in 60 participants. Completed in 15 May 2022.

Timeline
1 March 2021
Primary endpoint
15 May 2022
15 May 2022

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date1 March 2021
Primary completion15 May 2022
Estimated completion15 May 2022
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Eligibility, any sex, with Migraine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine the effects, sequel of dry needling in migraine by resolving MTrPs in sternocleidomastoid muscle. To determine the possession of dry needling technique to mitigate the frequency, intensity and duration of headache. To determine the effectiveness of dry needling in the disability hindrance in migraine patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dry Needling

Trials testing the same drug.

Other recruiting trials for Migraine

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05285852.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing